Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirsty Balachandran

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Lancet. Oncology|December 8, 2016
Turmeric: a spice for life?Kirsty Balachandran, Justin Stebbing
Oncology and Therapy|December 6, 2025
The Role of Comorbidities in Treatment Decision-Making across the Spectrum of Prostate Cancer: A PodcastPeter Whelan, Kirsty Balachandran, Kenrick Ng
Journal of Molecular Endocrinology|June 25, 2020
90 Years of progesterone: Ninety years of progesterone: the 'other' ovarian hormoneSimak Ali, Kirsty Balachandran, Bert O'Malley
BMC Cancer|April 18, 2015
Resolution of severe hyponatraemia is associated with improved survival in patients with cancerKirsty Balachandran, Alicia Okines, Ranga Gunapala, et al.
British Journal of Haematology|January 29, 2016
Bone marrow manifestations in multicentric Castleman diseaseHazem A H Ibrahim, Kirsty Balachandran, Mark Bower, et al.
Immunotherapy|February 5, 2014
The use of monoclonal antibodies to treat Castleman's diseaseRebecca C Robey, Salvinia Mletzko, Charlotte Colley, et al.
Journal of the Royal Society of Medicine|May 25, 2019
Cancer control in low- and middle-income countries: time for actionBerkin Hack, Katy Piddock, Susannah Stanway, et al.
Patient Preference and Adherence|January 26, 2019
Efficient development and usability testing of decision support interventions for older women with breast cancerKate J Lifford, Adrian Edwards, Maria Burton, et al.
Gynecologic Oncology|August 4, 2019
When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patientsKirsty Balachandran, Abdulazeez Salawu, Ehsan Ghorani, et al.
Breast (Edinburgh, Scotland)|November 4, 2021
Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK studySalma El Badri, Bilal Tahir, Kirsty Balachandran, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Lancet. Oncology|December 8, 2016
Turmeric: a spice for life?Kirsty Balachandran, Justin Stebbing
Oncology and Therapy|December 6, 2025
The Role of Comorbidities in Treatment Decision-Making across the Spectrum of Prostate Cancer: A PodcastPeter Whelan, Kirsty Balachandran, Kenrick Ng
Journal of Molecular Endocrinology|June 25, 2020
90 Years of progesterone: Ninety years of progesterone: the 'other' ovarian hormoneSimak Ali, Kirsty Balachandran, Bert O'Malley
BMC Cancer|April 18, 2015
Resolution of severe hyponatraemia is associated with improved survival in patients with cancerKirsty Balachandran, Alicia Okines, Ranga Gunapala, et al.
British Journal of Haematology|January 29, 2016
Bone marrow manifestations in multicentric Castleman diseaseHazem A H Ibrahim, Kirsty Balachandran, Mark Bower, et al.
Immunotherapy|February 5, 2014
The use of monoclonal antibodies to treat Castleman's diseaseRebecca C Robey, Salvinia Mletzko, Charlotte Colley, et al.
Journal of the Royal Society of Medicine|May 25, 2019
Cancer control in low- and middle-income countries: time for actionBerkin Hack, Katy Piddock, Susannah Stanway, et al.
Patient Preference and Adherence|January 26, 2019
Efficient development and usability testing of decision support interventions for older women with breast cancerKate J Lifford, Adrian Edwards, Maria Burton, et al.
Gynecologic Oncology|August 4, 2019
When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patientsKirsty Balachandran, Abdulazeez Salawu, Ehsan Ghorani, et al.
Breast (Edinburgh, Scotland)|November 4, 2021
Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK studySalma El Badri, Bilal Tahir, Kirsty Balachandran, et al.
Pageof 2